Showing results (21-30 of 51) with videos related to

Sort By:
Pageof 6
Neurologia Medico-Chirurgica|February 22, 2019
EGFRvIII Is Expressed in Cellular Areas of Tumor in a Subset of GlioblastomaTakanori Nozawa, Masayasu Okada, Manabu Natsumeda, et al.
Frontiers in Oncology|February 11, 2020
MGMT Expression Contributes to Temozolomide Resistance in H3K27M-Mutant Diffuse Midline GliomasHideaki Abe, Manabu Natsumeda, Masayasu Okada, et al.
NMC Case Report Journal|July 3, 2023
A Collision Tumor of Pit-1/SF-1-positive Double Pituitary Adenoma and a Craniopharyngioma Coexisting with Graves' DiseaseHaruhiko Kikuta, Shinya Jinguji, Taku Sato, et al.
Cancers|February 15, 2022
Novel Repositioning Therapy for Drug-Resistant Glioblastoma: In Vivo Validation Study of Clindamycin Treatment Targeting the mTOR Pathway and Combination Therapy with TemozolomideTakeyoshi Eda, Masayasu Okada, Ryosuke Ogura, et al.
Diagnostics (Basel, Switzerland)|April 30, 2021
Low Detection Rate of H3K27M Mutations in Cerebrospinal Fluid Obtained from Lumbar Puncture in Newly Diagnosed Diffuse Midline GliomasJotaro On, Manabu Natsumeda, Jun Watanabe, et al.
Thrombosis Research|January 27, 2023
Elevated ratio of C-type lectin-like receptor 2 level and platelet count (C2PAC) aids in the diagnosis of post-operative venous thromboembolism in IDH-wildtype gliomasKazuhiro Ando, Manabu Natsumeda, Masahide Kawamura, et al.
No Shinkei Geka. Neurological Surgery|March 24, 2020
[Coexisting Symptomatic Adrenocorticotropic Hormone- and Growth Hormone-producing Double Pituitary Adenomas with Difficulty in Tumor Localization:A Case Report]Yuhei Ito, Shinya Jinguji, Yusuke Sato, et al.
Expert Review of Anticancer Therapy|June 24, 2026
The dual role of Schlafen11 in brain tumors: Jekyll and HydeManabu Natsumeda, Masayasu Okada, Satoshi Nakata, et al.
JCI Insight|November 22, 2024
CRISPR/CasRx suppresses KRAS-induced brain arteriovenous malformation developed in postnatal brain endothelial cells in miceShoji Saito, Yuka Nakamura, Satoshi Miyashita, et al.
Brain Tumor Pathology|July 3, 2021
Predicting BRAF V600E mutation in glioblastoma: utility of radiographic featuresManabu Natsumeda, Michael Chang, Ramil Gabdulkhaev, et al.
Pageof 6